查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1662938

循环性肿瘤细胞全球市场报告 2025

Circulating Tumor Cells Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

循环性肿瘤细胞市场规模预计在未来几年将快速成长。到 2029 年，这一数字将成长至 216.8 亿美元，复合年增长率为 12.8%。预测期内的成长可归因照护现场CTC 检测、微射流的采用、对罕见癌症类型的关注、CTC 检测的标准化、基于 CTC 的临床试验的扩展、经济成长以及新兴市场的成长。预测期内的关键趋势包括 CTC 分离技术的创新、政府对 CTC 研究的资助、CTC 检测技术的进步、用于癌症监测的液态切片、与单细胞分析的整合以及与人工智慧 (AI) 的技术融合。

预计未来几年癌症发生率的增加将推动循环性肿瘤细胞市场的成长。癌症是一种以某些身体细胞不受控制地生长为特征的疾病，这些细胞可以转移到其他部位。循环性肿瘤细胞用于癌症的早期发现和诊断，因此癌症患者数量的增加促进了循环性肿瘤细胞市场的扩大。例如，自愿组织《美国癌症美国》预测，2023年1月，美国将有1,958,310例癌症新病例，609,820例癌症相关死亡病例。因此，癌症发生率的增加正在推动循环性肿瘤细胞市场的成长。

临床试验中越来越多地采用循环性肿瘤细胞分析也可能是市场成长的主要驱动力。临床试验对于评估新治疗方法的安全性和有效性至关重要，它受益于循环性肿瘤细胞(CTC) 分析的整合。这种整合将增强我们评估治疗反应的能力，实现更早的检测和监测，根据特定患者情况量身定制干预措施，并全面提高临床终点的效率和检验。截至 2023 年 5 月，ClinicalTrials.gov 报告称，已註册 452,604 项临床试验，其中 64,838 项正在积极寻找参与者。临床试验数量较 2021 年註册的 365,000 项试验增加，支持了循环性肿瘤细胞分析在研究中的日益普及。因此，CTC分析在临床试验中的日益整合是推动循环性肿瘤细胞市场发展的主要因素。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球循环性肿瘤细胞PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球循环性肿瘤细胞市场：成长率分析
  • 全球循环性肿瘤细胞市场表现：规模与成长，2019 年至 2024 年
  • 全球循环性肿瘤细胞市场预测：2024-2029 年及 2034 年规模与成长
  • 全球循环性肿瘤细胞总目标市场 (TAM)

第六章 市场细分

  • 全球循环性肿瘤细胞市场（依产品、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 套件和试剂
  • 采血管
  • 设备或系统
  • 全球循环性肿瘤细胞市场（按技术、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • CTC 富集
  • CTC检测
  • CTC分析
  • 全球循环性肿瘤细胞市场（依样本、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 血
  • 骨髓
  • 其他体液
  • 全球循环性肿瘤细胞市场（按应用、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 临床或液态生物检体
  • 调查
  • 全球循环性肿瘤细胞市场，按套件和试剂类型细分，性能和预测，2019-2024 年，2024-2029 年，2034 年
  • 细胞富集试剂套件
  • 检测试剂套件
  • 核酸分离试剂套件
  • 全球循环性肿瘤细胞市场，依采血管类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 标准采血管
  • 特殊采血管
  • 全球循环性肿瘤细胞市场，按设备或系统类型细分，性能和预测，2019-2024 年，2024-2029 年，2034 年
  • 微流体设备
  • 自动细胞捕获系统
  • 影像系统

第七章 区域和国家分析

  • 全球循环性肿瘤细胞市场：按地区、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球循环性肿瘤细胞市场：按国家、表现和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 循环性肿瘤细胞市场：竞争格局
  • 循环性肿瘤细胞市场：公司简介
    • Precision Medicine Group LLC Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
    • BIOCEPT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Creativ MicroTech Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fluxion Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Ikonisys Inc.
  • Qiagen NV
  • ScreenCell SAS
  • STEMCELL Technologies Inc.
  • Sysmex Corporation
  • Aviva Biosciences Corporation
  • LungLife AI Inc.
  • Miltenyi Biotec GmbH
  • Menarini Silicon Biosystems SpA
  • Canopus Bioscience Ltd.
  • IVDiagnostics Inc.
  • BioFluidica Inc.
  • Biolidics Limited
  • Rarecells Diagnostics SAS
  • LineaRx Inc.

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 循环性肿瘤细胞市场 2029：提供新机会的国家
  • 循环性肿瘤细胞市场 2029：提供新机会的细分市场
  • 循环性肿瘤细胞市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r23254

Circulating tumor cells (CTCs) represent solid tumor-derived cells that have detached from the primary tumor and entered the bloodstream, providing valuable diagnostic and prognostic information for cancer.

The primary products related to circulating tumor cells encompass kits and reagents, along with blood collection tubes and devices or systems. Kits and reagents constitute a comprehensive set of consumables comprising elements such as a blood specimen separator, proprietary microfluidic capture chip, CTC enrichment, and immunostaining reagents. These products are utilized for collecting various specimens from the human body, including blood, bone marrow, and other bodily fluids. They leverage different technologies such as CTC enrichment, detection, and analysis, facilitating applications in clinical or liquid biopsy procedures, as well as in research endeavors.

The circulating tumor cells market research report is one of a series of new reports from The Business Research Company that provides circulating tumor cells market statistics, including circulating tumor cells industry global market size, regional shares, competitors with a circulating tumor cells market share, detailed circulating tumor cells market segments, market trends and opportunities, and any further data you may need to thrive in the circulating tumor cells industry. This circulating tumor cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The circulating tumor cells market size has grown rapidly in recent years. It will grow from $11.9 billion in 2024 to $13.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to cancer incidence and prevalence, clinical utility in cancer staging, emergence of liquid biopsy, patient demand for minimally invasive tests, regulatory support for liquid biopsies, focus on early cancer detection.

The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $21.68 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to point-of-care CTC testing, adoption of microfluidics, focus on rare cancer types, standardization of CTC assays, expansion of CTC-based clinical trials, economic and emerging market growth. Major trends in the forecast period include innovations in CTC isolation techniques, government funding for CTC research, advancements in CTC detection technologies, liquid biopsy for cancer monitoring, integration with single-cell analysis, technological convergence with artificial intelligence (AI).

The increasing incidence of cancer is expected to drive the growth of the circulating tumor cells market in the future. Cancer is a disease characterized by the uncontrolled growth of certain body cells, which can spread to other areas. Circulating tumor cells are utilized for the early detection and diagnosis of cancer, thereby contributing to the expansion of the circulating tumor cells market as cancer cases rise. For example, in January 2023, the American Cancer Society Journals, a US-based voluntary health organization, projected that 1,958,310 new cancer cases would be diagnosed in the United States, with 609,820 expected cancer-related deaths. Thus, the rising incidence of cancer is fueling the growth of the circulating tumor cells market.

The increasing adoption of circulating tumor cells analysis in clinical trials is poised to be a significant driver for the market's growth. Clinical trials, essential for assessing the safety and efficacy of new medical treatments, benefit from the integration of circulating tumor cells (CTC) analysis. This integration enhances the ability to evaluate treatment response, enable early detection and monitoring, tailor interventions to specific patient profiles, and overall, improve the efficiency and validation of clinical endpoints. As of May 2023, ClinicalTrials.gov reported 452,604 registered clinical studies, with 64,838 actively seeking participants. This surge in clinical trials, up from 365,000 registered trials in 2021, underscores the increasing adoption of circulating tumor cells analysis in research. Consequently, the growing integration of CTC analysis in clinical trials is a key driver propelling the circulating tumor cells market.

Product innovations are a significant trend gaining traction in the circulating tumor cells market. Major companies in this sector are concentrating on developing innovative products to bolster their market position. For example, in June 2024, Bio-Rad Laboratories, Inc., a US-based medical laboratory, introduced the Celselect Slides 2.0. This product is designed to improve the capture of rare cells and circulating tumor cells (CTCs), thereby enhancing the accuracy and efficiency of cell analysis for both clinical and research applications.

Major players in the circulating tumor cells market are strategically focusing on the development of innovative products, particularly in the domain of oncology liquid biopsy, to drive revenue growth. Oncology liquid biopsy involves a minimally invasive or non-invasive technique for detecting and monitoring disease biomarkers present in bodily fluids such as blood, urine, and sputum. A case in point is BillionToOne Inc., a prominent US-based biotech company specializing in molecular diagnostics. In June 2022, the company introduced oncology liquid biopsy products, namely NorthStar Select and NorthStar Response. NorthStar Select is a comprehensive somatic mutation profiling panel designed for cancer, utilizing BillionToOne's unique molecular counting method, Quantitative Counting Templates (QCTs), to identify actionable mutations with a notable limit of detection. On the other hand, NorthStar Response is a tissue-neutral, methylation-based treatment response monitoring test, providing precise estimates of circulating tumor DNA (ctDNA) methylation burden through molecular counting technologies.

In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. This acquisition is intended to strengthen Cell Microsystems' capabilities in cell analysis and offer advanced solutions for both research and clinical applications. Fluxion Biosciences, also based in the US, specializes in technologies for isolating and analyzing circulating tumor cells (CTCs).

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the circulating tumor cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The circulating tumor cells market consists of sales of clinical samples, KRT7, PSMA positive cells, and TTF-1 positive. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Circulating Tumor Cells Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on circulating tumor cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for circulating tumor cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The circulating tumor cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Kits And Reagents; Blood Collection Tubes; Devices Or Systems
  • 2) By Technology: CTC Enrichment; CTC Detection; CTC Analysis
  • 3) By Specimen: Blood; Bone Marrow; Other Body Fluids
  • 4) By Application: Clinical Or Liquid Biopsy; Research
  • Subsegments:
  • 1) By Kits And Reagents: Cell Enrichment Kits; Detection Kits; Nucleic Acid Isolation Kits
  • 2) By Blood Collection Tubes: Standard Blood Collection Tubes; Specialized Blood Collection Tubes
  • 3) By Devices Or Systems: Microfluidic Devices; Automated Cell Capture Systems; Imaging Systems
  • Companies Mentioned: Precision Medicine Group LLC; Bio-Techne Corporation; BIOCEPT Inc.; Creativ MicroTech Inc.; Fluxion Biosciences Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Circulating Tumor Cells Market Characteristics

3. Circulating Tumor Cells Market Trends And Strategies

4. Circulating Tumor Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Circulating Tumor Cells Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Circulating Tumor Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Circulating Tumor Cells Market Growth Rate Analysis
  • 5.4. Global Circulating Tumor Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Circulating Tumor Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Circulating Tumor Cells Total Addressable Market (TAM)

6. Circulating Tumor Cells Market Segmentation

  • 6.1. Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits And Reagents
  • Blood Collection Tubes
  • Devices Or Systems
  • 6.2. Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CTC Enrichment
  • CTC Detection
  • CTC Analysis
  • 6.3. Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Bone Marrow
  • Other Body Fluids
  • 6.4. Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Or Liquid Biopsy
  • Research
  • 6.5. Global Circulating Tumor Cells Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Enrichment Kits
  • Detection Kits
  • Nucleic Acid Isolation Kits
  • 6.6. Global Circulating Tumor Cells Market, Sub-Segmentation Of Blood Collection Tubes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Blood Collection Tubes
  • Specialized Blood Collection Tubes
  • 6.7. Global Circulating Tumor Cells Market, Sub-Segmentation Of Devices Or Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microfluidic Devices
  • Automated Cell Capture Systems
  • Imaging Systems

7. Circulating Tumor Cells Market Regional And Country Analysis

  • 7.1. Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Circulating Tumor Cells Market

  • 8.1. Asia-Pacific Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Circulating Tumor Cells Market

  • 9.1. China Circulating Tumor Cells Market Overview
  • 9.2. China Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Circulating Tumor Cells Market

  • 10.1. India Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Circulating Tumor Cells Market

  • 11.1. Japan Circulating Tumor Cells Market Overview
  • 11.2. Japan Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Circulating Tumor Cells Market

  • 12.1. Australia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Circulating Tumor Cells Market

  • 13.1. Indonesia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Circulating Tumor Cells Market

  • 14.1. South Korea Circulating Tumor Cells Market Overview
  • 14.2. South Korea Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Circulating Tumor Cells Market

  • 15.1. Western Europe Circulating Tumor Cells Market Overview
  • 15.2. Western Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Circulating Tumor Cells Market

  • 16.1. UK Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Circulating Tumor Cells Market

  • 17.1. Germany Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Circulating Tumor Cells Market

  • 18.1. France Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Circulating Tumor Cells Market

  • 19.1. Italy Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Circulating Tumor Cells Market

  • 20.1. Spain Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Circulating Tumor Cells Market

  • 21.1. Eastern Europe Circulating Tumor Cells Market Overview
  • 21.2. Eastern Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Circulating Tumor Cells Market

  • 22.1. Russia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Circulating Tumor Cells Market

  • 23.1. North America Circulating Tumor Cells Market Overview
  • 23.2. North America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Circulating Tumor Cells Market

  • 24.1. USA Circulating Tumor Cells Market Overview
  • 24.2. USA Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Circulating Tumor Cells Market

  • 25.1. Canada Circulating Tumor Cells Market Overview
  • 25.2. Canada Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Circulating Tumor Cells Market

  • 26.1. South America Circulating Tumor Cells Market Overview
  • 26.2. South America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Circulating Tumor Cells Market

  • 27.1. Brazil Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Circulating Tumor Cells Market

  • 28.1. Middle East Circulating Tumor Cells Market Overview
  • 28.2. Middle East Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Circulating Tumor Cells Market

  • 29.1. Africa Circulating Tumor Cells Market Overview
  • 29.2. Africa Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Circulating Tumor Cells Market Competitive Landscape And Company Profiles

  • 30.1. Circulating Tumor Cells Market Competitive Landscape
  • 30.2. Circulating Tumor Cells Market Company Profiles
    • 30.2.1. Precision Medicine Group LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. BIOCEPT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Creativ MicroTech Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fluxion Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Circulating Tumor Cells Market Other Major And Innovative Companies

  • 31.1. Ikonisys Inc.
  • 31.2. Qiagen N.V.
  • 31.3. ScreenCell SAS
  • 31.4. STEMCELL Technologies Inc.
  • 31.5. Sysmex Corporation
  • 31.6. Aviva Biosciences Corporation
  • 31.7. LungLife AI Inc.
  • 31.8. Miltenyi Biotec GmbH
  • 31.9. Menarini Silicon Biosystems S.p.A.
  • 31.10. Canopus Bioscience Ltd.
  • 31.11. IVDiagnostics Inc.
  • 31.12. BioFluidica Inc.
  • 31.13. Biolidics Limited
  • 31.14. Rarecells Diagnostics SAS
  • 31.15. LineaRx Inc.

32. Global Circulating Tumor Cells Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Circulating Tumor Cells Market

34. Recent Developments In The Circulating Tumor Cells Market

35. Circulating Tumor Cells Market High Potential Countries, Segments and Strategies

  • 35.1 Circulating Tumor Cells Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Circulating Tumor Cells Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Circulating Tumor Cells Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer